Endpoints News 10 déc. 2025 #SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%
Endpoints News 4 déc. 2025 Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron